Efficacy News and Research

RSS
WHO issues interim policy guidance on inclusion of bedaquiline to treat adults with MDR-TB

WHO issues interim policy guidance on inclusion of bedaquiline to treat adults with MDR-TB

Investigational all-oral interferon-free combination from Boehringer Ingelheim achieves 95% viral cure rates in genotype-1b hepatitis C patients

Investigational all-oral interferon-free combination from Boehringer Ingelheim achieves 95% viral cure rates in genotype-1b hepatitis C patients

One-third of RA patients discontinue therapy within the first year of treatment

One-third of RA patients discontinue therapy within the first year of treatment

Tumor suppressor p53 inactivation and restoration: an interview with Dr. Xin Lu, Ludwig Institute for Cancer Research

Tumor suppressor p53 inactivation and restoration: an interview with Dr. Xin Lu, Ludwig Institute for Cancer Research

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Johns Hopkins researchers develop experimental vaccine for TB meningitis

Johns Hopkins researchers develop experimental vaccine for TB meningitis

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

ARIAD Pharmaceuticals initiates ponatinib Phase 2 trial in adult patients with metastatic GIST

ARIAD Pharmaceuticals initiates ponatinib Phase 2 trial in adult patients with metastatic GIST

Abbott starts ABSORB Japan trial to evaluate Absorb BVS in patients with CAD

Abbott starts ABSORB Japan trial to evaluate Absorb BVS in patients with CAD

Kessler Foundation receives grants from NJ Commission to study deficits in TBI patients

Kessler Foundation receives grants from NJ Commission to study deficits in TBI patients

Faldaprevir+ achieves viral cure in 88% of treatment-naïve genotype-1 hepatitis C patients in Asia

Faldaprevir+ achieves viral cure in 88% of treatment-naïve genotype-1 hepatitis C patients in Asia

Large study of deep brain stimulation underway for Alzheimer's disease treatment

Large study of deep brain stimulation underway for Alzheimer's disease treatment

Study shows Atkins diet is effective for long-term weight loss

Study shows Atkins diet is effective for long-term weight loss

Ingenol mebutate drug does not offer added benefit over diclofenac/hyaluronic acid gel

Ingenol mebutate drug does not offer added benefit over diclofenac/hyaluronic acid gel

ZOLL Autopulse improves ROSC after sudden cardiac arrest

ZOLL Autopulse improves ROSC after sudden cardiac arrest

New technique for developing complex protein drugs from bacteria

New technique for developing complex protein drugs from bacteria

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

BioLineRx starts enrollment in Phase 2 trial of BL-8040 for treatment of AML

BioLineRx starts enrollment in Phase 2 trial of BL-8040 for treatment of AML

Vanda reports clinical data of tasimelteon Phase III studies for treatment of Non-24-Hour Disorder

Vanda reports clinical data of tasimelteon Phase III studies for treatment of Non-24-Hour Disorder

Echo Therapeutics to evaluate safety, efficacy of Symphony CGM System in hospital setting

Echo Therapeutics to evaluate safety, efficacy of Symphony CGM System in hospital setting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.